The TCRN is a translational cancer research centre program funded by the Cancer Institute NSW
Welcome to the Nexus for February 2019
Ovarian Cancer Awareness Month is held each year in February to raise awareness of the signs and symptoms of ovarian cancer and to recognise women.
In this month's Nexus eNewsletter, we recognise some of our Ovarian Cancer research members, encourage General Practitioners to register for the Shared Care for Colorectal Cancer Workshop on March 12, provide an update on the Translational Program Grants and share interesting articles from our members.
The 'TCRN Operation and Project Team Employee Spotlight' Series is also introduced in this month's Nexus eNewsletter to gain some insight into the TCRN OPT's work and interests.
Detecting the Undetectable: A New Biomarker for Ovarian Cancer
Ovarian cancer is the 8th most common cancer affecting Australian women, with a relative five-year survival rate of 45 per cent. In 2016, 938 Australian women died of the disease. Learn more about TCRN supported PhD student Nicole Yuwono and her work.
TCRN Operation and Project Team Employee Spotlight Series - Fenglian Xu
Introducing the ‘TCRN Operation and Project Team Employee Spotlight’ Series. This month, we are launching the TCRN Operation and Project Team Employee Spotlight Series. Get to know a little more about our talented team!
Getting in CONTACT with Genetic Counselling Services
Access to cancer genetic services remains a challenge for many Australians – but a new research project will put patients in touch with world-leading genetics expertise with little more than the push of a button. Learn more about the TCRN funded CONTACT study.
The 2019 RCPAQAP Molecular Genetics Workshop will focus on tissue biobanking and the critical role biobanks have as a biorepository for the storage and access of key clinical material, not only for research but also for clinical diagnostics. TCRN members, Dr Carmel Quinn, Dr Anusha Hettiaratchi and Mamta Porwal, will be presenting at the workshop.
The Cancer CAG Announces Seed Grants for Four Interdisciplinary Projects
The Cancer CAG has committed almost $200,000 in new seed grants for four projects led by early- and mid-career researchers to be undertaken in 2019. Congratulations to the four successful teams, three of which are led by TCRN members.
TCRN members intending to submit a Cancer Institute NSW Translational Program Grant (TPG) will require a letter of support from the TCRN.
Please provide a brief synopsis of your project and list of Chief Investigators to email@example.com by 1 March.
Drug Development Conference 2019
The New South Wales Early Phase Clinical Trials Alliance (NECTA) presents the latest in cutting edge academic and pharmaceutical input into early phase drug development in Australasia and will be held on March 28 - March 29 at Garvan Institute of Medical Research.
In this monthly article the TCRN Operations & Projects team use on-line tools to identify publications attributed to TCRN members. We are using Scopus, the largest abstract and citation database of peer-reviewed literature as our primary source.